SXTP (60 Degrees Pharmaceuticals) Total Debt per Share: $0.06 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SXTP 60 Degrees Pharmaceuticals Inc SXTP
44 GF Score
Price $1.25
GF Value $1.98
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is 60 Degrees Pharmaceuticals Total Debt per Share?

60 Degrees Pharmaceuticals SXTP -16.11% 44 Total Debt per Share is $0.06 as of Mar. 2026. GuruFocus rates SXTP with a GF Score™ of 44/100 and a GF Value™ of $1.98 (Possible Value Trap). The stock has 5 warning signs investors should review.

$0.06 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. 60 Degrees Pharmaceuticals's Total Debt Per Share for the quarter that ended in Mar. 2026 was $0.06.

60 Degrees Pharmaceuticals Total Debt per Share Historical Data

* Premium members only.

The historical data trend for 60 Degrees Pharmaceuticals's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

60 Degrees Pharmaceuticals Total Debt per Share Chart

60 Degrees Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 817.61 974.70 7.17 1.10 0.13

60 Degrees Pharmaceuticals Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.42 0.15 0.13 0.06
SXTP
44GF Score
60 Degrees Pharmaceuticals Inc SXTP
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

60 Degrees Pharmaceuticals Total Debt per Share Calculation

60 Degrees Pharmaceuticals's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.14+0.01)/1.16
=0.13

60 Degrees Pharmaceuticals's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.14+0.01)/2.64
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $0.06 mean?
60 Degrees Pharmaceuticals (SXTP) has a Total Debt per Share of $0.06 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on 60 Degrees Pharmaceuticals and its competitors.
Is 60 Degrees Pharmaceuticals' Total Debt per Share too high?
60 Degrees Pharmaceuticals' current Total Debt per Share is $0.06. Overall, 60 Degrees Pharmaceuticals has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 60 Degrees Pharmaceuticals' Total Debt per Share compare to GNPX and GLMD?
60 Degrees Pharmaceuticals' Total Debt per Share of $0.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on 60 Degrees Pharmaceuticals and its competitors. 60 Degrees Pharmaceuticals's current Total Debt per Share is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 60 Degrees Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals (SXTP) is currently considered Possible Value Trap. The stock's GF Value™ is $1.98, compared to a current price of $1.25 — trading 36.9% below its estimated fair value. The current Total Debt per Share is $0.06. 60 Degrees Pharmaceuticals' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For 60 Degrees Pharmaceuticals (SXTP), the current Total Debt per Share is $0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 60 Degrees Pharmaceuticals (SXTP) Overvalued in 2026?

Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals stock appears to be undervalued. The current stock price of $1.25 is trading 36.9% below its estimated GF Value™ of $1.98. GuruFocus considers 60 Degrees Pharmaceuticals to be Possible Value Trap.

Key valuation signals for SXTP:

  • Total Debt per Share: $0.06
  • GF Value™: $1.98 vs. price of $1.25 (36.9% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the SXTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

60 Degrees Pharmaceuticals Business Description

Address 1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
44GF Score

Get the complete analysis for SXTP

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price
$1.98
GF Value